Skip to content

Ayurvedic treatment of swelling of gums with Priyangwadi Churna, Triphala Churna with or without Raktamokshana

Efficacy of Priyangavadi Churna Pratisarana,Triphala Churna orally ,with or without Raktamokshana(Prachchana Vidhi) in the management of Shitada (Gingivitis) - an open labelled randomized comparative clinical trial - nill

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064421
Enrollment
30
Registered
2024-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K050- Acute gingivitis

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient of either sex aged between 18 to 60 years of age presenting with signs and symptoms of Shitada(Gingivitis) described as per Ayurveda and Modern Science will be included in the study. 2.The diagnosis of the disease shall be done with signs and symptoms of Shitada(Gingivitis)i.e.Akasmata Rakta Srava (Bleeding), Shotha(Inflammation), Krishnata(Discoloration of gums), Mukha Daurgandhya (Halitosis), Vedana (Pain), DantamamsaPrakledata(Moistness), Paka (Pus discharge) and DantamamsaMriduta (Sponginess). 3.Patients having minimum two clinical symptoms of Shitada will be included in the study.Primary symptom is Akasmata Rakta Srava (Bleeding) along with any other symptom of Shitada.

Exclusion criteria

Exclusion criteria: 1.Patients below18 years and more than 60 years of age. 2.Patient with periodontal pocket with pus discharge. 3.Patients with evidence of malignancy, HIV and Diabetes Mellitus. 4.Any systemic disorder which may alter the result of the study i.e, Haemophilia or other bleeding disorders. 5.Pregnant women shall be excluded. 6.Patients who are using anticoagulant drugs like Aspirin etc. will be excluded. 7.The patients taking any other systemic drugs which can alter the result of the study.

Design outcomes

Primary

MeasureTime frame
Efficacy of intervention on signs and symptoms of Shitada (Gingivitis).Timepoint: during the treatment period at baseline 4 Weeks

Secondary

MeasureTime frame
Improvement in the quality of life of the patient Assessment of recurrence of signs & symptoms of Shitada (Gingivitis) during follow up periodTimepoint: During follow up period on 15th & 30th day

Countries

India

Contacts

Public ContactGanesh Dan

Institute of Teachig and Research in Ayurveda, Jamnagar

drvaghela@rediffmail.com9825407899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026